Skip to main content

Table 1 Baseline characteristics of the study population: Tehran Lipid and glucose study

From: External validation of the American prediction model for incident type 2 diabetes in the Iranian population

 

Total (N = 1835)

With T2DM (N = 281)

Without T2DM (N = 1554)

P-value

Sex, men

837(45.6)

123(43.8)

714(45.9)

0.5

Age, (years)

56.02(7.89)

56.5(7.6)

55.9(7.9)

0.22

Body mass index, (kgm2)

28.27(4.38)

29.9(4.6)

28.0(4.3)

< 0.001

Waist circumference, (cm)

95.21(10.33)

99.6(10.2)

94.4(10.2)

< 0.001

Systolic blood pressure, (mmHg)

122.76(18.25)

127.9(17.4)

121.8(18.3)

< 0.001

Diastolic blood pressure, (mmHg)

77.34(10.47)

79.7(10.6)

76.9(10.4)

< 0.001

Fasting plasma glucose, (mmol/L)

5.15(0.54)

5.62(0.59)

5.06(0.48)

< 0.001

High density lipoprotein cholesterol, (mmol/L)

1.02(0.27)

0.98(0.26)

1.03(0.27)

0.006

Triglycerides, (mmol/L)

1.72(1.12)

2.02(1.37)

1.64(1.05)

< 0.001

Family history diabetes, (yes)

249(13.6)

56(19.9)

193(12.4)

0.001

Follow-up duration, (years)

9.31(1.65)

9.4(1.71)

9.3(1.62)

0.17

  1. Data are shown as mean (SD) for continues and number (%) for categorical covariates; IQR: Interquartile range.SD: standard deviation; IQR: interquartile range